Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
GlucoTrack Announces 1-for-2 Reverse Stock Split Effective October 26, 2026

GlucoTrack Announces 1-for-2 Reverse Stock Split Effective October 26, 2026

BitgetBitget2026/10/22 13:03
  • GlucoTrack will implement a 1-for-2 reverse stock split effective at the opening of trading on October 26, 2026.
  • Outstanding common shares will fall from 2,368,237 to approximately 1,184,119.
  • The split aims to restore compliance with Nasdaq's $1 minimum bid price requirement.
  • Continued listing requires a closing bid price of at least $1 each trading day through November 9, 2026.
  • Fractional shares will be rounded up to the next whole share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610220900BIZWIRE_USPR_____20261022_BW412041) on October 22, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity

Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

智通财经•2026/11/12 01:01
Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity